| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seattle Genetics, Inc. | COM | 812578102 | $4,274,891 | 50,057,277 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,373,620 | 31,976,557 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $1,470,357 | 40,854,586 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $1,442,246 | 11,777,285 | SOLE | |||
| Alexion Pharmaceuticals, Inc. | COM | 15351109 | $808,795 | 8,258,068 | SOLE | |||
| Amarin Corporation plc | SPONSORED ADR | 23111206 | $629,811 | 41,544,288 | SOLE | |||
| Genomic Health, Inc. | COM | 37244C101 | $626,973 | 9,244,665 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $511,518 | 7,589,294 | SOLE | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $326,551 | 3,390,270 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $169,435 | 8,792,678 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $131,507 | 9,145,116 | SOLE | |||
| Neurocrine Biosciences, Inc. | COM | 64125C109 | $127,531 | 1,415,283 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $116,189 | 1,019,557 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $111,335 | 6,018,104 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $101,846 | 1,307,220 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $100,815 | 1,169,278 | SOLE | |||
| MyoKardia, Inc. | COM | 62857M105 | $79,124 | 1,517,237 | SOLE | |||
| Spark Therapeutics, Inc. | COM | 84652J103 | $72,922 | 751,927 | SOLE | |||
| Tricida, Inc. | COM | 89610F101 | $60,811 | 1,969,905 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $58,470 | 2,708,200 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $55,806 | 3,144,000 | SOLE | |||
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | $55,471 | 2,345,496 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $55,416 | 10,749,937 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $47,382 | 5,509,560 | SOLE | |||
| Principia Biopharma Inc. | COM | 74257L108 | $46,710 | 1,654,029 | SOLE | |||
| Atreca, Inc. | CL A Common | 04965G109 | $43,241 | 3,532,760 | SOLE | |||
| GW Pharmaceuticals plc | ADS | 36197T103 | $42,658 | 370,845 | SOLE | |||
| Zymeworks Inc. | COM | 98985W102 | $42,370 | 1,708,472 | SOLE | |||
| Audentes Therapeutics, Inc. | COM | 05070R104 | $42,316 | 1,506,438 | SOLE | |||
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $42,113 | 30,770,000 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $39,333 | 2,229,760 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $36,458 | 12,725,472 | SOLE | |||
| Adaptive Biotechnologies Corporation | COM | 00650F109 | $36,011 | 1,165,411 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $35,929 | 1,034,674 | SOLE | |||
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $32,221 | 11,305,679 | SOLE | |||
| CymaBay Therapeutics, Inc. | COM | 23257D103 | $29,222 | 5,707,411 | SOLE | |||
| Allakos Inc. | COM | 01671P100 | $26,710 | 339,690 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $23,824 | 2,799,577 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $20,671 | 1,160,014 | SOLE | |||
| uniQure N.V. | SHS | N90064101 | $20,377 | 517,700 | SOLE | |||
| UroGen Pharma Ltd. | COM | M96088105 | $17,819 | 747,751 | SOLE | |||
| Axsome Therapeutics, Inc. | COM | 05464T104 | $15,631 | 772,286 | SOLE | |||
| BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | $14,722 | 15,000,000 | SOLE | |||
| Xencor, Inc. | COM | 98401F105 | $14,440 | 428,120 | SOLE | |||
| Aimmune Therapeutics, Inc. | COM | 00900T107 | $14,112 | 673,908 | SOLE | |||
| Protagonist Therapeutics, Inc. | COM | 74366E102 | $14,103 | 1,174,282 | SOLE | |||
| La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | $13,721 | 1,559,231 | SOLE | |||
| Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | $13,319 | 4,608,786 | SOLE | |||
| Aeglea BioTherapeutics, Inc. | COM | 00773J103 | $13,178 | 1,713,604 | SOLE | |||
| Alkermes plc | SHS | G01767105 | $12,194 | 625,030 | SOLE |